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ABSTRACT
We developed an electronic treatment register for the DeWorm3 Project, a cluster- 
randomised, controlled trial in Benin, India, and Malawi testing the feasibility of interrupting 
transmission of soil-transmitted helminths through community-wide mass drug administra-
tion. The electronic treatment register was designed in xlsform, deployed via the SurveyCTO 
mobile data collection platform, and implemented on smartphones running the Android 
operating system. The versatile system enables collection of census and treatment status 
information, facilitates data aggregation and visualisation, and permits real-time feedback 
loops during implementation of mass drug administration. Here we describe the system’s 
design and use within the DeWorm3 Project and key features, and by sharing the register 
here, we hope our readers will further explore its use within their research and disease- 
control activities.
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Background
Population treatment coverage is a fundamental indi-
cator of mass drug administration (MDA) perfor-
mance for neglected tropical disease (NTD) 
programmes [1,2]. Defined as the proportion of the 
targeted population who swallows the recommended 
drug or drug combination, treatment coverage is 
ideally measured at point of delivery, based on 
directly observed treatment [1,3]. Data collection 
during MDA routinely uses paper treatment registers 
or tally-sheets to record and summarise numbers 
treated by sex and age. These data must ultimately 
be tabulated and reported at the implementation unit 
level and then nationally. This approach may lead to 
compromised data quality due to user error, delayed 
implementation feedback and reporting, and an 
increased workload for community drug distributors 
(CDDs) and health information officers. Critically, 
systematically missed populations or coverage equity 
cannot be readily or reliably identified using this 
approach, despite recognition of the importance of 
high coverage and compliance in reaching WHO 
Roadmap targets [2].
Electronic data collection for public health using 
mobile phones or devices, or mHealth, has increased 
in recent years, matching availability and function-
ality of phone and internet technologies. Use of 
mobile devices for large-scale NTD prevalence sur-
veys has been described [4,5], and, though examples 
exist of applying mobile technology for monitoring 
MDA for NTD control [6–9], a recent review high-
lighted the lack of documentation of mHealth inter-
ventions [10].
Here, we describe the creation and application of 
an innovative electronic data collection and monitor-
ing system for registering individuals and their treat-
ment status during community-wide MDA activities 
implemented for the DeWorm3 Project [11]. This 
system can improve quality, accuracy, and compre-
hensiveness of MDA data, facilitate household target-
ing, and reduce time needed to access data for 
implementation monitoring.
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The DeWorm3 Project (ClinicalTrials.gov Identifier 
NCT03014167) is a multi-site cluster-randomised, con-
trolled trial conducted in Benin, India, and Malawi. The 
project has been described previously, but, briefly, 
DeWorm3 aims to test feasibility of interrupting trans-
mission of soil-transmitted helminths (STH) through 
three years of expanded MDA targeting all community 
members [11]. Study clusters were randomised to receive 
either the standard of care (current national STH MDA 
strategy) or intervention. In the trial’s intervention arm, 
biannual, community-wide MDA with a single dose of 
albendazole (GlaxoSmithKline) is delivered house-to- 
house by CDDs targeting approximately 55,000 
individuals.
Development and application of the electronic 
treatment register for DeWorm3
Drawing from experience from the TUMIKIA Project 
[12], we designed the electronic treatment register for 
the DeWorm3 Project to avoid the challenges with 
paper-based data collection described above, while 
permitting real- or near real-time implementation 
and coverage monitoring. At the time of develop-
ment, we knew of no existing system for mobile 
data collection during MDA that could be adapted 
to meet the needs of the project and that would sit 
alongside the project’s other data collection tools and 
workflows. Towards this, the register was developed 
in xlsform (xlsform.org) for use with SurveyCTO 
(Dobility, Inc; Cambridge, MA, USA) running on 
Android smartphones.
The register is used by field officers accompanying 
CDDs as they treat. The development process involved 
extensive field-based piloting, working with site data 
teams to optimise and translate the register for use 
under varied contexts and technological constraints. 
For example, the Malawi site lacks widespread cellular 
data access, so data are submitted when field officers are 
able to access internet hotspots. In contrast, at the India 
and Benin sites, data are submitted after each household 
visit. The xlsform and associated files are available at the 
following link (https://github.com/williameoswald/ 
deworm3_etr), and setup and use protocols are avail-
able from the DeWorm3 research toolkit (http://www. 
nhm.ac.uk/our-science/our-work/sustainability/ 
deworm3/research-tool-kit.html). A functional web 
version of the register (http://tinyurl.com/y2azojsc) 
and dashboard (https://tinyurl.com/y3rx3w88) are also 
available.
Trial site data systems are built upon a comprehensive 
listing of villages, higher administrative units, and an 
annually updated household census to enumerate resi-
dents and collect socioeconomic information and dwell-
ing GPS coordinates. Household information, including 
each member’s name, age, and sex, is assembled into 
a dataset that is pre-loaded in the electronic treatment 
register. Field officers access the register in their local 
language through the SurveyCTO app and use displayed 
resident information to record receipt of treatment or 
reason for non-treatment (Figure 1).
Figure 1. The electronic treatment register (ETR) data system for enumerating populations and registering individual treatment 
during community-wide mass drug administration.
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Results
Improving data quality with a dynamic treatment 
register
The dataset attached to the register is dynamic, meaning 
household, individual, and treatment information is 
updated on field officers’ smartphones to reflect 
changes between visits. Beyond the logic checks and 
range constraints programmed within the electronic 
treatment register, this dynamic dataset improves data 
quality. For example, tracking individual presence and 
treatment between visits avoids duplication of records 
on paper registers that might occur if households 
receive multiple visits by different CDDs.
Provision of a population denominator
The electronic register enables collection of accurate 
community-level population information, necessary 
for calculating treatment coverage. DeWorm3 activ-
ities benefit from a pre-MDA census, but if there are 
new household members encountered during a visit, 
their information and treatment status can be col-
lected and then updated at later visits. In the same 
way, new households can also be added to the dataset. 
This dynamic functionality would allow either: (1) 
a pre-MDA census to first list a community’s house-
holds and residents, which is then updated with treat-
ment status during MDA; or (2) resident 
demographic and treatment information to be col-
lected during MDA, starting from an empty dataset.
A flexible tool to facilitate treatment
The electronic treatment register facilitates targeting of 
households, improves comprehensiveness, and reduces 
workload. Households to be targeted are listed within 
the register and are then automatically filtered to 
remove them from this listing once all members have 
been treated. Using an approach provided by Dobility, 
Inc., GPS coordinates are displayed in the form as 
a uniform resource locator (URL) that can then be 
viewed in Google Maps (Google LLC, Mountain View, 
CA, USA) to navigate to targeted households. Finally, 
the register is flexible to treatment delivery location. 
Field officers choose to record treatment of an entire 
household (all members) or, after making at least one 
visit to a household’s dwelling, to record treatment of 
a single member of that household found elsewhere in 
the community (e.g. at work).
Real-time monitoring and reactive 
decision-making
Electronic collection means data are readily available 
for analysis and visualisation. Household treatment 
summaries are calculated per visit within the register, 
removing need for manual calculation. These summa-
ries are submitted as part of the household record to the 
SurveyCTO server where they are automatically pseu-
donymised and assembled into a monitoring dataset. 
This household monitoring dataset is then published 
from the SurveyCTO server to a dashboard in Google 
Sheets (Google LLC, Mountain View, CA, USA), where 
it is further aggregated by cluster, date, and field officer. 
Access to SurveyCTO and the household level data on 
Google is restricted to specific users. The dashboard 
then displays treatment summaries, allowing a wider 
group of users to monitor progress and coordinate 
implementation during MDA (Figure 2).
Discussion
Here we present our electronic treatment register as 
a data collection system. The backbone of the system is 
the provided xlsform, and this tool can be modified by 
anyone with experience authoring such forms in 
Microsoft Excel (Microsoft Corporation, Redmond, 
WA, USA). We developed the electronic treatment 
register to be implemented via SurveyCTO, but the 
provided xlsform and described process, including 
data management, aggregation, and visualisation, 
could potentially be implemented via free data collec-
tion and analysis platforms, like Open Data Kit [13] 
and R (r-project.org). By sharing our tool and 
a description of our MDA data collection process, we 
aim to facilitate future data collection activities for 
researchers and provide an additional tool for poten-
tially strengthening programmatic data collection.
The WHO recently recommended the use of electro-
nic data collection and storage, or ‘digital tracking’ of 
health information, with decision support in settings 
where integration of such interventions can be sup-
ported by the health system and for tasks within the 
scope of practice for the health worker [14]. In line with 
similar recommendations that community health work-
ers could document the services they provide using 
relevant mobile health solutions [15], the electronic 
treatment register, though developed for a research pro-
ject, is simple to use and could incorporate graphics 
instead of text for users with limited literacy. Coupled 
with availability of inexpensive smartphones and grow-
ing internet access, the register provides a versatile plat-
form to replace paper-based data collection, 
aggregation, and analysis workflows. Collected data 
can then be more readily acted upon during implemen-
tation, easily integrated within national information 
system platforms (e.g. DHIS2), and more easily accessed 
for the completion of preventive chemotherapy dona-
tion reporting requirements [16]. Users should, how-
ever, consider and comply with local ethical and data 
protection standards.
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Conclusion
Our electronic treatment register could potentially 
improve MDA data quality and accuracy and time-
liness of feedback and reporting, which in turn may 
boost coverage. We now encourage readers to further 
explore and adapt the use of our register within their 
own research or disease control activities.
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Paper context
Paper-based approaches for recording treatment during mass 
drug administration (MDA) are widely used but contribute to 
high implementer workloads and may compromise data qual-
ity. Resulting data may not be available in time to act upon to 
improve coverage during MDA. For the DeWorm3 project, 
we developed an ‘Electronic Treatment Register’ that we have 
used to enumerate populations and accurately track treat-
ments provided in real-time, improving timeliness of report-
ing and strengthening data use towards maximising coverage.
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